Calumet Specialty Products Partners shares reached an all-time high of $58.44, marking a nearly 210% increase over the past year despite concerns of being overvalued.
Calumet Specialty Products Partners stock reached a 52-week high of $54.72, surging over 200% annually despite mixed Q2 2026 results. S&P Global Ratings upgraded the firm to 'B-' alongside updated pri
Wellington Management Group LLP reduced its stake in Calumet, Inc. by 2.3% in Q2, selling 19,076 shares while retaining holdings worth $29.2 million despite mixed analyst sentiment.
HC Wainwright raised its price target for Calumet Specialty Products Partners to $75, citing a 40.8% year-over-year revenue increase. Despite missing earnings expectations, the firm maintains a buy ra
Analysts assigned Calumet, Inc. a 'Hold' rating with a $48 target despite 40.8% revenue growth. The company missed earnings, though institutional investors significantly increased their positions.
Calumet Specialty Products Partners stock hit a 52-week high of $51.51, driven by strong Q2 results and performance in specialty oils and renewable fuels.
S&P Global Ratings upgraded Calumet Specialty Products Partners' credit rating to "B-", citing strong first-half 2026 earnings and performance in specialty oils and renewable fuels. The stable outlook
UBS raised its price target for Calumet Specialty Products Partners to $47 from $26, maintaining a Neutral rating. This update reflects an improved analyst outlook on the oil and gas refining company.
Calumet Specialty Products Partners announced plans to attend the Barclays 40th Annual Energy-Power Conference on September 10, 2026, for investor meetings. The company manufactures specialty branded
Calumet Inc shares fell 3.5% to $47.28, though GuruFocus assesses the stock as significantly overvalued by 159.4%. The company remains unprofitable with negative cash flow and notable insider selling.
Calumet Inc shares rose 5.1%, but GuruFocus rates the stock significantly overvalued at $50.81 against an intrinsic value of $18.23. Concerns over unprofitability and insider selling advise investor c
Calumet Specialty Products Partners stock reached a new 52-week high of $49.17, boosting market cap to $4.31 billion despite a Q2 adjusted EPS loss. TD Cowen raised its price target to $40 while maint
Calumet Specialty Products Partners reported increased Q2 sales but a wider first-half net loss driven by profitability pressures. Its investment strategy hinges on shifting to renewables and specialt
Bank of America increased its stake in Calumet Specialty Products Partners by 65.1% in Q1. Calumet reported a 40.8% revenue increase but missed earnings estimates with an adjusted loss.
Calumet Specialty Products Partners faces mixed valuation signals as Strait of Hormuz tensions drive up Brent crude prices. Analysts debate whether the stock is overvalued at $47.19 due to debt and re
Calumet Specialty Products Partners shares surged to a 12-month high of $45.55, driven by a 40.8% year-over-year revenue increase to $1.45 billion, despite reporting an adjusted loss of $1.09 per shar
Calumet Specialty Products Partners stock reached a 52-week high of $45.20 following strong Q2 2026 revenue of $1.44 billion. Analysts forecast profitability for the year despite recent losses and an
Calumet Specialty Products Partners shares climbed nearly 12% to $44.22, marking its highest closing level since November 2007 with significant year-to-date growth.
Calumet, Inc. received a consensus Hold rating after missing earnings expectations, despite a 40.8% revenue increase and insider sales driving a 5.7% share price drop.
Calumet Specialty Products Partners reported quarterly earnings missing consensus estimates by $1.16 per share despite a 40.8% revenue increase to $1.45 billion. Following the announcement, shares fel
Calumet, Inc. (CLMT) stock data and financial history are detailed in this overview. The company specializes in specialty chemicals and renewable fuels, offering analyst insights for investors.
Renaissance Technologies LLC initiated a new investment in Calumet Specialty Products Partners, purchasing 391,800 shares worth approximately $14.1 million, despite mixed financial sentiment.
Calumet Inc. shares rose 1.01% to $44.19, holding a $3.85 billion market cap. Analysts rate the renewable fuel and specialty products maker a Buy despite weak fundamentals, setting a target price of $
Healthcare of Ontario Pension Plan Trust Fund increased its stake in Calumet, Inc. by 107% in Q1 to $3.5 million, though analysts maintain a 'Hold' rating amid mixed insider signals.
HC Wainwright issued a Q2 2027 earnings forecast of $0.19 per share for Calumet Specialty Products Partners, maintaining a Buy rating with a $60 price target. This outlook surpasses the broader analys
Rangeley Capital LLC reduced its stake in Calumet Specialty Products Partners by 79.6% to approximately $1.9 million in Q1. Calumet reported a quarterly EPS loss despite a 3.6% year-over-year revenue
Lombard Odier Asset Management cut its position in Calumet Specialty Products Partners by 40.5% to $2.14 million in Q1, following wider-than-expected losses and insider selling.
Calumet Specialty Products Partners reached a new 52-week high of $44.17 despite missing EPS estimates, while analysts remain divided with a consensus Hold rating and $36.75 price target.
AnalystConsensusTarget raised Calumet Specialty Products Partners' fair value to $41.08, citing improved margins and revenue growth. The company is actively deleveraging by redeeming senior notes to r
Calumet Specialty Products Partners redeemed $100 million of senior notes to improve its capital structure and reduce interest burdens. The move supports the company's transition toward renewables whi
Calumet Specialty Products Partners stock hit a 52-week high of $41.39; despite a Q1 earnings miss, revenue beat expectations and $100M in senior notes will be redeemed.
Calumet, Inc. secured a consensus Hold rating with a $36.75 price target following an EPS miss and revenue beat. Insider selling occurred alongside a marginal share price rise.
Calumet Specialty Products Partners stock reached a 52-week high of $38.88 despite analyst forecasts of losses and a recent Q1 earnings miss. The company also announced plans to redeem $100 million in
Calumet Specialty Products Partners reached a new 52-week high trading near $39.50 despite missing earnings expectations with a negative EPS. Analyst sentiment remains mixed, with HC Wainwright raisin
Calumet Specialty Products Partners will redeem $100 million of 9.75% Senior Notes due 2028 on July 15, 2026. The company aims to strengthen its balance sheet and reduce interest expenses through this
Calumet Specialty Products Partners will redeem $100 million in senior notes at 102.438% of principal to strengthen its balance sheet. Shares rose 4.36% following the announcement of reduced interest
Calumet Specialty Products Partners will redeem $100 million in senior notes to strengthen its balance sheet and reduce interest expenses. The renewable fuel and specialty product maker aims to improv
Calumet Specialty Products Partners (CLMT) is a U.S. refiner of specialty petroleum products and fuels. Its MLP structure emphasizes cash generation and distribution sustainability amid volatile energ
Calumet Specialty Products Partners stock closed at $32.68 on June 18, 2026, amidst broader energy sector volatility. Performance was driven by crude oil prices and refinery margins rather than specif
AYAL Capital Advisors reduced its stake in Calumet Specialty Products Partners by 53.2% in Q4, selling 221,645 shares, while other institutional investors increased their positions despite a Hold anal
AI models analyze Calumet Specialty Products Partners (CLMT) stock trends, identifying oscillation patterns and trading strategies. The analysis notes weak near-term sentiment but a strong mid-to-long
Calumet Specialty Products Partners released SEC filings including 10-K, 10-Q, and 8-K forms. Updates detail Heritage Group's ownership changes and director equity awards reported via Form 4 filings.
Calumet Specialty Products Partners stock reached a 52-week high of $36.97, reflecting a 172.94% increase over the past year. Despite strong performance, the company remains unprofitable after missing
Calumet Specialty Products Partners trades above fair value despite earnings growth, highlighted by a Montana SAF expansion project and a $30 million operational setback in Shreveport due to contamina
Linscomb Wealth Inc. sold 30,000 shares of Calumet Specialty Products Partners, reducing its stake by 53.7%. This follows Calumet's wider-than-expected quarterly loss, although revenue slightly exceed
Calumet Specialty Products Partners announced attendance at the Bank of America Energy and Power Credit Conference on June 4, 2026, for investor meetings. The company manufactures specialty branded pr
Calumet Specialty Products Partners confirmed participation in the Goldman Sachs Leverage Finance Conference on May 28, 2026.
Calumet Specialty Products Partners is scheduled to release Q1 2026 earnings on May 8th, with analysts projecting a $0.57 loss per share on $1.0011 billion revenue. Market sentiment remains neutral wi
Calumet, Inc. received a consensus 'Hold' rating with a $30.50 price target after reporting a 9.4% revenue increase to $1.04 billion and beating EPS estimates.
Calumet Specialty Products Partners shares dropped 6.2% to $30.75 despite exceeding Q4 estimates, as analysts maintain a 'Hold' rating while hedge funds increase stakes.
ChemBrief